These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23067922)

  • 1. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization.
    Sarkar S; Koehler J; Crossley GH; Tang WH; Abraham WT; Warman EN; Whellan DJ
    Am Heart J; 2012 Oct; 164(4):616-24. PubMed ID: 23067922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous versus intermittent monitoring of ventricular rate in patients with permanent atrial fibrillation.
    Ziegler PD; Koehler JL; Verma A
    Pacing Clin Electrophysiol; 2012 May; 35(5):598-604. PubMed ID: 22394432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Ezekowitz MD; Hilker C; Miller C; Qi D; Ziegler PD
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):474-80. PubMed ID: 19843914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.
    Puglisi A; Gasparini M; Lunati M; Sassara M; Padeletti L; Landolina M; Botto GL; Vincenti A; Bianchi S; Denaro A; Grammatico A; Boriani G;
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):693-701. PubMed ID: 18328039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
    Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
    Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.
    Ahluwalia N; Koehler J; Sarkar S; Vasudevan N; Majumder S; Landman SR; Schilling RJ
    Circ Arrhythm Electrophysiol; 2024 Aug; 17(8):e012842. PubMed ID: 38939945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension.
    Gorczyca-Michta I; Wożakowska-Kapłon B; Tomasik E
    Kardiol Pol; 2013; 71(4):352-8. PubMed ID: 23788340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN; Jhaveri M; Lin J
    Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial tachyarrhythmias temporally precede fluid accumulation in implantable device patients.
    Andriulli JA; Moore HJ; Hettrick DA; Ousdigian KT; Johnson J; Markowitz SM
    Pacing Clin Electrophysiol; 2014 May; 37(5):554-61. PubMed ID: 24341570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.